Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sterigmatocystin 7-O-methyltransferase, commonly referred to as O-methyltransferase A (OmtA), is a vital enzyme in the aflatoxin biosynthetic pathway of fungi such as Aspergillus flavus and Aspergillus parasiticus [1, 2]. It catalyzes the S-adenosyl-L-methionine (SAM)-dependent methylation of sterigmatocystin (ST) to form O-methylsterigmatocystin (OMST), a key penultimate step in the production of the potent hepatocarcinogen aflatoxin B1 [2, 14]. Due to the severe health impacts of aflatoxins, which include acute toxicosis and a high risk of hepatocellular carcinoma in humans, OmtA is considered a significant target for anti-aflatoxigenic intervention [1, 14]. Current research focuses on discovering small-molecule inhibitors like piperlonguminine and blasticidin S, and employing gene-silencing techniques like Host-Induced Gene Silencing (HIGS) to reduce toxin levels in crops [2, 4]. By targeting this enzymatic step, biotechnologists aim to block the synthesis of toxic metabolites while preserving the ecological niche of the fungus [2]. Safety and efficacy evaluations are crucial to ensure that inhibitors do not interfere with host methyltransferase systems or cause broader environmental damage [1, 12].
Inhibition of the enzymatic conversion of sterigmatocystin to O-methylsterigmatocystin in the aflatoxin biosynthetic pathway [1, 2].
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sterigmatocystin 7-O-methyltransferase (OmtA) (OmtA).